18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors

Launched by HUNAN CANCER HOSPITAL · Aug 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging technique called 18F-FAPI-04 PET/CT and PET/MR to see how well it can help doctors find and assess different types of cancer. The goal is to determine if this method can effectively identify primary tumors (the original cancer) and metastatic lesions (cancer that has spread), as well as help monitor if the cancer is coming back or how well treatment is working.

To participate, patients should be aged between 65 and 74 and have suspected or newly diagnosed malignant tumors. This means they may have had previous tests like MRI or CT scans showing signs of cancer. It's important to note that pregnant individuals and those with non-cancerous conditions are not eligible for this trial. If someone decides to join, they will provide informed consent, which means they agree to participate after understanding what the trial involves. Participants can expect to undergo the imaging tests in a safe and supportive environment, helping researchers learn more about this potential new tool in cancer care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
• Exclusion Criteria:
• • patients with non-malignant lesions; patients with pregnancy; the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.